Page Title
Clinical Trial Finder
Observational Closed to Enrollment
GI symptoms observational study (GALAXY) (GALAXY-OB-18)
This study will collect information on gastrointestinal (GI) symptoms that people with CF experience.
This study will require a single visit where participants will enroll in the study and take four questionnaires. Participants will take these questionnaires at three different times outside the clinic. Researchers will evaluate the results to learn about CF GI symptoms and treatment.
Eligibility
-
Age:
2 Years and Older -
Mutation(s):
No Mutation Requirement -
FEV1% Predicted:
No FEV1 Limit
For more information about the results of this study and where it was conducted, visit ClinicalTrials.gov.
Study Design
-
Study Type: ?more info
Observational -
Randomized Study: ?more info
No -
Placebo Controlled: ?more info
No -
Length of Participation:
29 days -
Number of Study Visits:
1
Additional Information
-
Phase: ?more info
Not Applicable -
Study Sponsor: ?more info
-
Study Drugs:
N/A
Study Sites
-
Closed to Enrollment
California
Stanford University Medical Center, Palo Alto, CA 94304
-
Closed to Enrollment
Connecticut
Central Connecticut Cystic Fibrosis Center, Hartford, CT 06106
-
Closed to Enrollment
District of Columbia
Children's National Medical Center, Washington, DC 20010
-
Closed to Enrollment
Florida
All Children's Hospital, St. Petersburg, FL 33701
-
Closed to Enrollment
Florida
Nemours Children's Health - Pensacola, Pensacola, FL 32514
-
Closed to Enrollment
Georgia
Children’s Healthcare of Atlanta and Emory University, Atlanta, GA 30329
-
Closed to Enrollment
Illinois
OSF HealthCare Children’s Hospital of Illinois, Saint Francis Medical Center, Peoria, IL 61637
-
Closed to Enrollment
Illinois
Northwestern University, Chicago, IL 60611
-
Closed to Enrollment
Indiana
Riley Hospital for Children, Indianapolis, IN 46202
-
Closed to Enrollment
Kentucky
University of Kentucky, Lexington, KY 40506
-
Closed to Enrollment
Maine
Maine Medical Center, Portland, ME 04102
-
Closed to Enrollment
Massachusetts
University of Massachusetts Memorial Health Care, Worcester, MA 01655
-
Closed to Enrollment
Massachusetts
Boston Children's Hospital, Brigham & Women's Hospital, Boston, MA 02115
-
Closed to Enrollment
Michigan
Corewell Health Helen DeVos, Grand Rapids , MI 49503
-
Closed to Enrollment
Minnesota
The Minnesota Cystic Fibrosis Center, Minneapolis, MN 55455
-
Closed to Enrollment
Missouri
SSM Health Cardinal Glennon Children’s Hospital, St. Louis, MO 63104
-
Closed to Enrollment
New Jersey
Rutgers - Robert Wood Johnson Medical School, New Brunswick, NJ 08903
-
Closed to Enrollment
North Carolina
Atrium Health Wake Forest Baptist, Winston-Salem, NC 27157
-
Closed to Enrollment
North Carolina
Atrium Health Pulmonary Care, Charlotte, NC 28204
-
Closed to Enrollment
Ohio
Nationwide Children's Hospital, Columbus, OH 43205
-
Closed to Enrollment
Oklahoma
Oklahoma Cystic Fibrosis Center, OKC, OK 73104
-
Closed to Enrollment
Oregon
Oregon Health & Science University, Portland, OR 97239
-
Closed to Enrollment
Pennsylvania
Children's Hospital of Philadelphia, Philadelphia, PA 19104
-
Closed to Enrollment
Texas
University of Texas Southwestern / Children’s Health, Dallas, TX 75207
-
Closed to Enrollment
Utah
Primary Children's Cystic Fibrosis Center, Salt Lake City, UT 84113
-
Closed to Enrollment
Vermont
University of Vermont Medical Center, Burlington, VT 05401
Eligibility
-
Age:
2 Years and Older -
Mutation(s):
No Mutation Requirement -
FEV1% Predicted:
No FEV1 Limit
For more information about the results of this study and where it was conducted, visit ClinicalTrials.gov.
CONTACT THE CLINICAL TRIAL NAVIGATOR
Get personalized assistance and answers to your clinical trial questions.
Learn MoreSign up for clinical trial alerts
Get email updates about clinical trials that matter to you.
Check the Drug Development Pipeline
We’re attacking CF from every angle. Learn about the status of CF drugs in development.
Learn More